Document is current
Any future updates will be listed below
-
Authors
Pao, Ping-Chieh https://orcid.org/0000-0001-6788-7185
Patnaik, Debasis https://orcid.org/0000-0002-9829-3352
Watson, L. Ashley
Gao, Fan
Pan, Ling
Wang, Jun
Adaikkan, Chinnakkaruppan
Penney, Jay
Cam, Hugh P.
Huang, Wen-Chin
Pantano, Lorena https://orcid.org/0000-0002-3859-3249
Lee, Audrey
Nott, Alexi https://orcid.org/0000-0002-2029-7193
Phan, Trongha X.
Gjoneska, Elizabeta
Elmsaouri, Sara
Haggarty, Stephen J. https://orcid.org/0000-0002-7872-168X
Tsai, Li-Huei https://orcid.org/0000-0003-1262-0592
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG046174)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS102730)
Glenn Foundation for Medical Research
- License Information
-
More Information
Article History
Received: 28 March 2019
Accepted: 28 April 2020
First Online: 18 May 2020
Competing interests
: S.J.H. is a member of the scientific advisory board of Psy Therapeutics and Frequency Therapeutics neither of whom were involved in the present study. L.-H.T. and S.J.H. are also co-founders and members of Scientific Advisory Board of Souvien Therapeutics. L.-H.T., S.J.H., P.-C.P., D.P. and L.Pan have licensed intellectual property related to HDAC1 activators. The remaining authors declare no competing interests.
